The Bradykinin B2 Receptor Agonist (NG291) Causes Rapid Onset of Transient Blood–Brain Barrier Disruption Without Evidence of Early Brain Injury

Background: The blood–brain barrier (BBB) describes the brain’s highly specialized capillaries, which form a dynamic interface that maintains central nervous system (CNS) homeostasis. The BBB supports the CNS, in part, by preventing the entry of potentially harmful circulating molecules into the bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Massó, Sergio R., Erickson, Michelle A., Banks, William A., Ulrich, Henning, Martins, Antonio Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715084/
https://www.ncbi.nlm.nih.gov/pubmed/34975388
http://dx.doi.org/10.3389/fnins.2021.791709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715084/
https://www.ncbi.nlm.nih.gov/pubmed/34975388
http://dx.doi.org/10.3389/fnins.2021.791709

Ejemplares similares